164 completed, 32 unknown, 20 recruiting, 16 terminated. 247 Phase 2, 36 Phase 3, 33 Phase 1.
Follow Exercise: new trials by email Literature Review of Exercise trials Research Report on Exercise
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Moxifloxacin, Placebo - Endophthalmitis | Phase 2 / Phase 3 | Not yet recruiting | Jason Ahee, M.D. | 60000 | 2027-06-01 | 2026-09-15 |
| Duloxetine and aeRobic Exercise to Improve Function in VEterans With Knee Osteoarthritis (DRIVE) Exercise, Duloxetine, Placebo - Knee Osteoarthritis, Pain | Phase 2 | Not yet recruiting | VA Office of Research and Development | 102 | 2027-03-01 | 2026-06-16 |
| Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS Exercise - Parkinson's Disease, Deep Brain Stimulation | Phase 2 | Recruiting | The Cleveland Clinic | 36 | 2026-07-08 | 2026-10-26 |
| Cocoa to Maximize Exercise Training in Older Adults - The COMET Trial (-)-Epicatechin-rich cocoa supplementation combined with exercise training, Placebo combined with exercise training - Mobility Disability | Phase 1 / Phase 2 | Recruiting | University of Alabama at Birmingham | 36 | 2026-04-21 | 2026-05-08 |
| Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia nutritional intervention, Exercise, Peiyuan Guben Tongluo Ointment (Ejiao concentrated) - Sarcopenia in Elderly | Phase 2 | Not yet recruiting | Shanghai Yueyang Integrated Medicine Hospital | 60 | 2026-04-01 | 2026-04-20 |
| Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Rutin + Vitamin C, Vitamin C 500mg, Lifestyle Intervention - NAFLD | Phase 2 | Not yet recruiting | Ain Shams University | 120 | 2026-01-01 | 2025-12-30 |
| Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid Depression Ketamine hydrochloride, Minimally Enhanced Usual Care, Brief narrative intervention - Chronic Low Back Pain, Depression | Phase 2 | Recruiting | VA Office of Research and Development | 44 | 2025-12-03 | 2025-12-18 |
| Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu Whole-body resistance training and aerobic exercise - Metastatic Breast Cancer | Phase 2 | Recruiting | University of Utah | 80 | 2025-11-04 | 2026-08-20 |
| Exercise Therapy and Physical Activity Modification for Patients With Sever's Disease Exercise, Active Control - Apophysitis; Calcaneus | Phase 2 | Recruiting | California State University, Fullerton | 60 | 2025-10-30 | 2026-11-10 |
| Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV Tesamorelin, Placebo, Exercise - HIV-1-infection, Frailty | Phase 2 | Recruiting | Massachusetts General Hospital | 100 | 2025-07-10 | 2026-05-19 |
| Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients Carbocysteine 375 MG, Physical activity, walking, and calorie restriction - Non-Alcoholic Fatty Liver Disease | Phase 2 | Recruiting | Tanta University | 46 | 2025-03-01 | 2026-05-04 |
| Impact of LLL and Aerobic Exercise on Peripheral Arterial Outcomes in Patients With Type 2 Diabetes aerobic exercise + low-level laser therapy, Aerobic exercise - Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Completed | Nouran Hesham Slama Younis | 40 | 2025-02-20 | 2025-08-19 |
| Double Dose 4-AP on Functional Recovery After Spinal Cord Injury Dalfampridine, Placebo, STDP stimulation - SCI - Spinal Cord Injury | Phase 1 / Phase 2 | Recruiting | Shirley Ryan AbilityLab | 27 | 2025-02-01 | 2026-06-03 |
| IMPACT 360 for Parkinson's Disease Exercise, Meditation, Diet - Parkinson's Disease (PD), REM Sleep Behavior Disorder | Phase 2 | Active not recruiting | University of British Columbia | 60 | 2024-10-28 | 2026-06-25 |
| Empagliflozin Reversal of Arterial StiffnEss in Aging Empagliflozin 10 MG, Placebo - Aging, Arterial Stiffness | Phase 2 / Phase 3 | Recruiting | University of Missouri-Columbia | 80 | 2024-08-18 | 2026-02-06 |
| The MUSE Study for Menopausal Arthralgia Menopausal hormone therapy, Exercise training, Menopausal hormone therapy + exercise training - Arthralgia, Menopause | Phase 2 / Phase 3 | Recruiting | National University Hospital, Singapore | 100 | 2024-08-01 | 2024-07-31 |
| Vasodilator and Exercise Study for DMD (VASO-REx) Tadalafil, Placebo, Exercise Training - Duchenne Muscular Dystrophy, Duchenne Disease | Phase 2 | Recruiting | University of Florida | 50 | 2024-06-05 | 2026-05-15 |
| A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy Clenbuterol, Placebo - Spinal and Bulbar Muscular Atrophy | Phase 2 | Recruiting | Gianni Soraru | 90 | 2024-04-13 | 2024-04-15 |
| The IMPACT Implementation-Effectiveness Trial Exercise, Self-management e-module - Cancer | Phase 2 | Recruiting | McMaster University | 129 | 2024-03-15 | 2026-10-16 |
| Enhancing Modulation Effects of Baduanjin Through Neuromodulation for Knee OA BDJ, tDCS, sham tDCS - Knee Osteoarthritis | Phase 2 | Recruiting | Massachusetts General Hospital | 140 | 2024-03-05 | 2026-07-17 |
Showing 20 of 247. Sign in to see all of them.
Motor Activity (82) · Obesity (21) · Cardiovascular Diseases (15) · Breast Neoplasms (11) · Insulin Resistance (11) · Depression (10) · Diabetes Mellitus (8) · Diabetes Mellitus, Type 2 (8) · Neoplasms (8) · Heart Diseases (7) · Hypertension (7) · Non-alcoholic Fatty Liver Disease (7) · Osteoarthritis, Knee (7) · Pulmonary Disease, Chronic Obstructive (6) · Dermatitis, Atopic (5)
Sun Pharmaceutical Industries, Inc. (9) · National Heart, Lung, and Blood Institute (NHLBI) (6) · Duke University (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (4) · Vanderbilt University (4) · Institut de Recherches Cliniques de Montreal (3) · Kaiser Permanente (3) · Massachusetts General Hospital (3) · Northwestern Health Sciences University (3) · Norwegian University of Science and Technology (3) · Santalis Pharmaceuticals, Inc. (3) · Stanford University (3) · University Health Network, Toronto (3) · University of British Columbia (3) · University of Florida (3)
United States (133) · Canada (28) · Germany (9) · Denmark (7) · Brazil (6) · Norway (6) · United Kingdom (6) · Spain (5) · Belgium (4) · Mexico (4) · Netherlands (4) · Australia (3) · China (3) · Egypt (3) · Italy (3)
Alp Ikizler, MD (4) · Shabbir MH Alibhai, MD, MSc (3) · Eileen G. Collins, PhD RN (2) · Gert Bronfort, DC, PhD (2) · Harry Prapavessis, PhD (2) · Thomas Buford, PhD (2) · Adam G Tsai, MD, MSCE (1) · Alan M Rathbun, PhD MPH (1) · Alan Smyth, Prof (1) · Alexander R Lucas, PhD (1) · Alexander Scott, PhD (1) · Alice S. Ryan, PhD (1) · Allard Johane, MD, FRCPC (1)
PMID 25091629, PMID 29976553, PMID 32390133, PMID 33210751, PMID 35018639, PMID 11739090, PMID 12221344, PMID 12525233, PMID 14655916, PMID 14678952, PMID 15087413, PMID 15159321, PMID 15175588, PMID 15213282, PMID 15229337, PMID 15243275, PMID 15247119, PMID 15247126, PMID 15298949, PMID 15539040, PMID 15556826, PMID 15585547, PMID 15681521, PMID 15824183, PMID 15833948, PMID 15943960, PMID 16232102, PMID 16531889, PMID 16826020, PMID 16909130, PMID 16985018, PMID 17020620, PMID 17071161, PMID 17087620, PMID 17167156, PMID 17287149, PMID 17507612, PMID 17557987, PMID 17855695, PMID 17940108, PMID 18006923, PMID 18155998, PMID 18202351, PMID 18202581, PMID 18403448, PMID 18501061, PMID 18821656, PMID 18923311, PMID 19130989, PMID 19333174
R01DK045604 (3), R01HL135183 (2), 2009 (1), 2015 (1), 2023 (1), IK2CX002646-01A2 (1), K01AG064041 (1), K01HL161419 (1), K07CA168886 (1), K23AT001879 (1), K23DA019950 (1), K24DK065018 (1), P50GM060338 (1), R01AG018198 (1), R01AG075684 (1)